With separating agent (9mL vacuum blood sampling tube)
Storage method: Room temperature
Expiration period: 1 year from production
2024/04/10→大原
2019/01/29
未確認
未確認
未確認
未確認
未確認
未確認
未確認
未確認
未確認
未確認
未確認
2020/11/20
2024/04/10
A00
旧容器記号 X
ポリスピッツ
貯蔵方法：室温
A00
Previous container symbol
X
Polyethylene test tube
Storage method: Room temperature
補足情報
2024/10/11→大原
2019/12/24
2019/12/24
2020/01/31
2020/01/31
2020/01/31
2020/01/31
2020/01/31
未確認
未確認
未確認
2020/01/31
2020/01/31
2020/11/26
2024/10/11
胃がんリスク層別化検査 (ABC分類)〔LA〕
報告書
胃がんリスク層別化検査 (ABC分類)〔LA〕
の注意事項
以下の場合には、正しい結果が得られない可能性があります。
明らかな上部消化器症状のある方
上部消化管疾患治療中の方
プロトンポンプ阻害剤服用中の方
胃切除をされた方
腎不全の方
ピロリ菌の除菌治療を受けた方
Gastric Cancer Risk Stratification Test (ABC Classification) [LA] Report
ABC Classification
Helicobacter Pylori Antibody
< 10 (-)
≥ 10 (+)
Pepsinogen
(-)
Group A
Group B
(1+) - (3+)
Group D
Group C
Group A
Generally healthy gastric mucosa and low risk of gastric disease.
Pay attention to diseases not related to H. pylori, such as reflux esophagitis.
Although most likely uninfected, a portion of the population includes those with
H. pylori infection or a history of infection. It is ideal to undergo an imaging test such as endoscopy at least once.
Group B
Slightly weakened gastric mucosa. Pay attention to gastric and duodenal ulcers.
There is also a risk of gastric cancer. Undergo an endoscopic examination.
Treatment for eradication of H. pylori is recommended.
Group C
Weakened gastric mucosa with advanced atrophy.
This type is prone to gastric cancer.
Regular endoscopic examinations are recommended.
Eradication of H. pylori is also recommended.
Group D
Gastric mucosa with very advanced atrophy.
There is a risk of developing gastric cancer and other diseases.
Diagnosis of H. pylori infection is recommended.
Please consult a specialized medical institution for diagnosis, such as an endoscope.
Group E
Those who have undergone eradication of
H. pylori should undergo regular endoscopic examinations as Group E (eradication group)
regardless of the result of the eradication determination.
Although the risk of developing gastric cancer in group E is reduced by eradication, it is not zero, so endoscopic follow-up is necessary even after eradication.
Precautions for Gastric Cancer Risk Stratification Test (ABC Classification) [LA]
Correct results may not be obtained in the following cases:
Those with obvious upper gastrointestinal symptoms
Patients undergoing treatment for upper gastrointestinal tract diseases
Those taking proton pump inhibitors
Patients who have undergone gastrectomy
Those with renal failure
Those who have undergone H. pylori eradication treatment
